BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28184414)

  • 21. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.
    Kaneshiro DK; Post JC; Rybicki L; Rice TW; Goldblum JR
    Am J Surg Pathol; 2011 May; 35(5):697-700. PubMed ID: 21490446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer.
    Dilworth MP; Nieto T; Stockton JD; Whalley CM; Tee L; James JD; Noble F; Underwood TJ; Hallissey MT; Hejmadi R; Trudgill N; Tucker O; Beggs AD
    Ann Surg; 2019 Mar; 269(3):479-485. PubMed ID: 29384778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Yokoi K; Harada H; Yokota K; Ishii S; Tanaka T; Nishizawa N; Shimazu M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Feb; 26(2):406-414. PubMed ID: 30311169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection.
    Qumseya BJ; Panossian AM; Rizk C; Cangemi DJ; Wolfsen C; Raimondo M; Woodward TA; Wallace MB; Wolfsen HC
    Dig Liver Dis; 2013 Dec; 45(12):1028-33. PubMed ID: 23938135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of tumor ploidy and histomorphological parameters in adenocarcinoma of Barrett's esophagus.
    Böttger T; Dutkowski P; Kirkpatrick CJ; Junginger T
    Dig Surg; 1999; 16(3):180-5. PubMed ID: 10436364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barrett's esophagus: cancer and molecular biology.
    Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
    Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
    Brock MV; Gou M; Akiyama Y; Muller A; Wu TT; Montgomery E; Deasel M; Germonpré P; Rubinson L; Heitmiller RF; Yang SC; Forastiere AA; Baylin SB; Herman JG
    Clin Cancer Res; 2003 Aug; 9(8):2912-9. PubMed ID: 12912936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
    Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
    PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
    Fujiyama Y; Kumamoto Y; Nishizawa N; Nakamoto S; Harada H; Yokota K; Tanaka Y; Igarashi K; Oiki H; Okuwaki K; Iwai T; Kajita S; Takahashi H; Tajima H; Kaizu T; Sasaki J; Watanabe M; Yamashita K
    Ann Surg Oncol; 2020 Oct; 27(10):4007-4016. PubMed ID: 32144623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience.
    Biswas Roy S; Banks P; Kunz M; Ipsen TR; Masuda T; Mittal SK; Smith MA; Bremner RM
    Ann Thorac Surg; 2019 Apr; 107(4):1017-1023. PubMed ID: 30481513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.
    Rudolph RE; Vaughan TL; Storer BE; Haggitt RC; Rabinovitch PS; Levine DS; Reid BJ
    Ann Intern Med; 2000 Apr; 132(8):612-20. PubMed ID: 10766679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
    Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
    Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
    Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.